OnCo
drugsProductNot mapped hereapproved

Lomustine (CCNU)

An old chemotherapy pill used when glioblastoma comes back, and the control arm most new glioblastoma drugs must beat.

Standard second-line agent in Europe and the control in EORTC 26101 (lomustine ± bevacizumab), REGOMA, and most recurrent-glioblastoma trials; median OS ~8-9 months at recurrence. CeTeG/NOA-09 suggested lomustine-temozolomide improves OS in MGMT-methylated newly diagnosed disease. Delayed, cumulative myelosuppression limits cycles.

Loading structure…
|
Lomustine
PubChem
Modality
Oral nitrosourea chemotherapy
Mechanism
Lipophilic nitrosourea; DNA alkylation and crosslinking; crosses the blood-brain barrier.
Brand / code
Gleostine

Regulatory

1top

Approvals

RegionYearIndication
US1976Brain tumours after surgery/radiation; Hodgkin lymphoma

Trials

top
ClinicalTrials.gov · phase 2/3
refreshed 2026-09-09
105 studies11 recruiting62 Phase 246 Phase 3
Search “Lomustine” on ClinicalTrials.gov →
Counts are from a name search and may include unrelated studies; up to 100 studies are summarised.

Recruiting now (live from ClinicalTrials.gov)

Recruiting trials near you · live from ClinicalTrials.gov
Lomustine (CCNU)
intervention: Lomustine
Open on ClinicalTrials.gov →

Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.

Latest papers

top
Literature trend58 papers in the last 12 months+16% vs prior 12How this is computed
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this drug: (TITLE:"Lomustine" OR ABSTRACT:"Lomustine" OR TITLE:"CCNU" OR ABSTRACT:"CCNU" OR TITLE:"Gleostine" OR ABSTRACT:"Gleostine") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Lomustine (CCNU), not a curated reading list.

Connected

7top